Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Merck & Co., Inc. ( MRK ) - Merck & Co ( NYSE:MRK )
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Merck & Co., Inc. ( ...
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
SAN DIEGO and TORONTO, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Aptose Biosciences Inc. ( "Aptose" or the "Company" ) ( NASDAQ: APTO, TSX: APS ) , a clinical-stage precision oncology company developing the tuspetinib ( TUS ) -based triple drug frontline therapy to treat patients with newly diagnosed ...
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
SAN DIEGO, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Travere Therapeutics, Inc. ( NASDAQ: TVTX ) today announced it will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the close of the U.S. financial markets.
GCL and RF Acquisition Corp. Complete Business Combination, GCL to Commence Trading on Nasdaq Under Ticker "GCL" and Announces Bell Ringing to Commemorate Listing
GCL & RF Acquisition Corp. Complete Business Combination, GCL Commence Trading on Nasdaq Ticker "GCL" & Announces Bell Ringing to Commemorate Listing ...
Precision Optics Reports Second Quarter Fiscal Year 2025 Financial Results
Conference Call Scheduled for today, February 13, 2025, at 5:00pm ET. Conference Call Scheduled for today, February 13, 2025, at 5:00pm ET.
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization ( ECCO ) in Inflammatory Bowel Diseases 2025
AUSTIN, TX & DURHAM, NC, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Shattuck Labs, Inc. ( Shattuck ) ( NASDAQ: STTK ) , a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor ( TNF ) superfamily receptors for the treatment of patients with inflammatory ...
Aureus Greenway Holdings Inc. Announces the Closing of its Initial Public Offering
Kissimmee, FL, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Aureus Greenway Holdings Inc. ( the "Company" ) ( NASDAQ: AGH ) , an owner and operator of daily fee golf country clubs in the state of Florida, announced today the closing of its initial public offering ( the "Offering" ) of 3,750,000 shares of ...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635 ( c ) ( 4 )
ANN ARBOR, Mich., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Esperion ( NASDAQ: ESPR ) today announced that on February 11, 2025, the Company granted ten new employees 58,300 restricted stock units ( RSUs ) under Esperion's 2017 Inducement Equity Incentive Plan.
Actelis Networks Appoints Leading Industry Expert Julie Kunstler as Board Member - Actelis Networks ( NASDAQ:ASNS )
FREMONT, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Actelis Networks, Inc. ASNS ( "Actelis" or the "Company" ) , a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the appointment of Julie Kunstler as an independent ...
GCL and RF Acquisition Corp. Complete Business Combination, GCL to Commence Trading on Nasdaq Under Ticker "GCL" and Announces Bell Ringing to Commemorate Listing - RF Acquisition ( NASDAQ:RFAC )
GCL and RF Acquisition Corp. Have Closed the Business Combination on February 13, 2025 GCL's Ordinary Shares and Warrants Will Begin Trading on Nasdaq on February 14, 2025, Under Ticker Symbols "GCL" and "GCLWW," Respectively GCL to Ring the Closing Bell at Nasdaq on Friday, February 14, 2025